Investigating barriers in HIV-testing oncology patients. The IBITOP study: phase I

BACKGROUND: Since the advent of combined antiretroviral therapy (ART), the incidence of non-AIDS-defining cancers (non-ADCs) among HIV-positive patients is rising. We previously described HIV testing rates of <5% in our oncology centre, against a local HIV prevalence of 0.4% [1]. We have since wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Merz, Laurent, Peters, Solange, Zimmermann, Stefan, Cavassini, Matthias, Darling, Katharine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P090
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224909/
https://www.ncbi.nlm.nih.gov/pubmed/25394126
http://dx.doi.org/10.7448/IAS.17.4.19622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224909/
https://www.ncbi.nlm.nih.gov/pubmed/25394126
http://dx.doi.org/10.7448/IAS.17.4.19622

Ejemplares similares